SUCCESSFUL COST EFFECTIVE PREVENTION OF CYTOMEGALOVIRUS DISEASE IN KIDNEY TRANSPLANT RECIPIENTS USING LOW DOSE VALGANCICLOVIR

被引：1
|
作者：
Halim, Medhat [1 ]
Alotaibi, Torki [1 ]
Gheith, Osama [2 ]
Adel, Hany [1 ]
Mosaad, Ahmed [1 ]
Abo-Atteya, Hassanein [1 ]
Zakareya, Zakareya [1 ]
Said, Tarek [1 ]
Nair, Prasad [1 ]
Nampoory, Naryanan [1 ]
机构：
[1] OTC, Nephrol, Kuwait, Kuwait
[2] MUNC, Nephrol, Kuwait, Kuwait
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2015年 / 30卷
关键词：
D O I：
10.1093/ndt/gfv185.54
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
FP865
引用
收藏
页数：1
相关论文
共 50 条
  • [1] SUCCESSFUL COST EFFECTIVE PREVENTION OF CYTOMEGALOVIRUS DISEASE IN KIDNEY TRANSPLANT RECIPIENTS USING LOW DOSE VALGANCICLOVIR
    Gheith, Osama
    Al Otaibi, Torki
    Halim, Medhat A.
    Mansour, Hany
    Mansour, Hany
    Mosaad, Ahmed
    Attia, Hasanein
    Elsayed, Zakaria
    Elsayed, Zakaria
    Said, Tarek
    Nair, Prasad
    Nampoory, Naryanan
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2016, 31 : 1568 - 1568
  • [2] Successful Cost-Effective Prevention of Cytomegalovirus Disease in Kidney Transplant Recipients Using Low-Dose Valganciclovir
    Gheith, Osama
    Halim, Medhat A.
    Al-Otaibi, Torki
    Mansour, Hany
    Mosaad, Ahmed
    Atteya, Hassanein Abo
    Zakaria, Zakaria
    Said, Tarek
    Nair, Prasad
    Nampoory, Naryanam
    EXPERIMENTAL AND CLINICAL TRANSPLANTATION, 2017, 15 : 156 - 163
  • [3] COST BENEFIT OF CYTOMEGALOVIRUS DISEASE PREVENTION IN KIDNEY TRANSPLANT RECIPIENTS USING LOW DOSE VALGANCICLOVIR
    Gheith, Osama
    Halim, Medhat Abdul
    Al-Otaibi, Torki
    Adel, Hany
    Musaad, Ahemd
    Nair, Prasad
    TRANSPLANT INTERNATIONAL, 2017, 30 : 87 - 87
  • [4] EFFICACY AND SAFETY OF LOW DOSE VERSUS FULL DOSE VALGANCICLOVIR FOR PREVENTION OF CYTOMEGALOVIRUS DISEASE IN KIDNEY TRANSPLANT RECIPIENTS
    Halim, Medhat Abdel
    Al-Otaibi, Torki
    Gheith, Osama
    Adel, Hany
    Mosaad, Ahmed
    Abo-Atteya, Hassaneen
    Zakaria, Zakaria
    Said, Tarek
    Nair, Prasad
    Nampoory, Mrn
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2015, 30
  • [5] EFFICACY AND SAFETY OF LOW DOSE VERSUS FULL DOSE VALGANCICLOVIR FOR PREVENTION OF CYTOMEGALOVIRUS DISEASE IN KIDNEY TRANSPLANT RECIPIENTS
    Abdel-Halim, Medhat
    Al-Otaibi, Torki
    Gheith, Osama
    Adel, Hany
    Mosaad, Ahmed
    Abo-Atya, Hasaneen
    Zakaria, Zakaria
    Said, Tarek
    Nair, Prasad
    Nampoory, Mrn
    TRANSPLANT INTERNATIONAL, 2015, 28 : 155 - 155
  • [6] SUCCESSFUL COST EFFECTIVE PREVENTION OF CYTOMEGALOVIRUS DISEASE IN KIDNEY TRANSPLANT
    Gheith, Osama
    Alotaibi, Torki
    Halim, Medhat A.
    Adel, Hany
    Mosaad, Ahmed
    Atteya, Hasanein
    Zakareia, Zakareia
    Said, Tarek
    Nair, Prasad
    Nampoory, Naryanan
    TRANSPLANT INTERNATIONAL, 2015, 28 : 1 - 1
  • [7] Evaluation of Low Dose Valganciclovir for the Prevention of Cytomegalovirus in Liver Transplant Recipients
    Payne, C.
    Melaragno, J.
    Hutchinson, D.
    Babu, T.
    Prasad, P.
    Dick, T.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2017, 17 : 577 - 578
  • [8] EFFICACY AND SAFETY OF LOW DOSE VERSUS HIGH DOSE VALGANCICLOVIR FOR PREVENTION OF CYTOMEGALOVIRUS DISEASE IN INTERMEDIATE RISK KIDNEY TRANSPLANT RECIPIENTS
    Halim, Medhat Abdel
    Al-Otaibi, Torki
    Gheith, Osama
    Adel, Hany
    Mosaad, Ahmed
    Abu-Atteya, Hassaneen
    Zakaria, Zakaria
    Makkeya, Yahia
    Said, Tarek
    Nair, Prasad
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2016, 31 : 1568 - 1569
  • [9] Efficacy and safety of low-dose valganciclovir in the prevention of cytomegalovirus disease in adult liver transplant recipients
    Park, JM
    Lake, KD
    Arenas, JD
    Fontana, RJ
    LIVER TRANSPLANTATION, 2006, 12 (01) : 112 - 116
  • [10] Efficacy and safety of low-dose valganciclovir for the prevention of cytomegalovirus disease in liver transplant recipients.
    Park, JM
    Arenas, JD
    Fontana, RJ
    Lake, KD
    AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 : 502 - 502
12345